R&D Programs

Active Programs

Nine active programs across prosthetics, mobility, spinal systems, and AI — each with a clear path from research to the people it will help.

All Programs

9 Active Programs

From fundamental research to clinical deployment — every program has a defined development path and a clearly identified patient population it serves.

Prosthetics

BF-7 Bionic Arm Program

Phase II Trial

Full-arm myoelectric prosthetic system with 16-axis control. Currently in Phase II clinical trial — 94% task completion rate for activities of daily living.

Prosthetics Engineering Neural Interface
Research area →
Prosthetics

Multi-Articulating Hand Program

Validation

Individually articulating bionic hand with grip-force sensing and vibrotactile feedback. Entering clinical validation with prosthetic clinics in three states.

Prosthetics Engineering AI Control
Research area →
Mobility

BF-EX3 Exoskeleton Program

Pilot Program

Full lower-body exoskeleton for non-ambulatory users. 12-participant pilot complete — all participants walked. Scaling to expanded trial.

Exoskeleton Engineering Intent Detection
Research area →
Mobility

Active Ankle-Foot Orthosis Program

Deployed

Lightweight powered AFO for foot drop and partial lower-extremity paresis. Deployed through clinical partner network in 8 states.

Gait Systems Clinical Implementation
Research area →
Mobility

Post-Stroke Gait Recovery Program

Research

Structured exoskeleton-assisted gait retraining protocol for stroke survivors — driving high-repetition gait training to leverage neuroplasticity and extend recovery.

Neurorehabilitation Gait Systems
Research area →
Spine

Targeted Epidural Stimulation Program

Clinical Trial

Targeted epidural stimulation protocol for voluntary movement restoration in chronic complete SCI. Latest trial: voluntary leg movement in 5 of 5 participants.

Spinal Neuroscience Implant Engineering
Research area →
Spine

Epidural-Exoskeleton Integration Program

Applied Research

Combining epidural stimulation with powered exoskeleton for volitional walking after complete SCI — bridging neuromodulation and robotic assistance.

Spinal Neuroscience Exoskeleton Engineering
Research area →
Technology

Neural Interface Platform Program

FDA Breakthrough

High-channel cortical recording interface for direct motor intent capture. FDA Breakthrough Device Designation received April 2026 — accelerating clinical pathway.

Neural Interface Neurosurgery Partners
Research area →
Technology

Adaptive AI Control Program

Deployed

Personalized movement model running on all Foundation devices — continuously learning user-specific intent patterns, improving device performance over time.

AI Control Software Engineering
Research area →

Collaborate on a Program

We welcome researchers, clinicians, and engineers who want to contribute to active Foundation programs. Reach out to discuss how your work fits.

Get in Touch →
An initiative of the Odegard Foundation · Founded 2016 by Philip Odegard